n-methyl-3,4-methylenedioxyamphetamine has been researched along with eticlopride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, KT; Budreau, D; Rebec, GV | 1 |
| Bubar, MJ; Cunningham, KA; Frankel, PS; Pack, KM | 1 |
| Brennan, KA; Carati, C; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Harper, DN | 1 |
| Schenk, S; van de Wetering, R | 1 |
5 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and eticlopride
| Article | Year |
|---|---|
Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Benzazepines; Corpus Striatum; Dopamine Antagonists; Drug Interactions; Electrophysiology; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neural Inhibition; Neurons; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Time Factors | 2003 |
Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.
Topics: Animals; Benzazepines; Discrimination Learning; Dopamine D2 Receptor Antagonists; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Serotonin; Stereoisomerism | 2004 |
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Topics: Animals; Antipsychotic Agents; Benzazepines; Central Nervous System; Cocaine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Self Administration | 2009 |
Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists.
Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Psychomotor Performance; Rats; Receptors, Dopamine D1; Recognition, Psychology; Salicylamides; Time Factors | 2013 |
Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D
Topics: Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Locomotion; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Self Administration; Serotonin Agents | 2017 |